Recommended Topic Related To:

Survanta

"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...

Survanta

Survanta Patient Information including How Should I Take

What should I discuss with my health care provider before my child receives beractant (Survanta)?

To best participate in the care of your baby while he or she is in the NICU, carefully follow all instructions provided by your baby's caregivers.

How is beractant given (Survanta)?

Beractant is given directly into the baby's lungs through a breathing tube. Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.

The breathing tube is connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).

Beractant is given as soon as possible after the baby's birth, usually within minutes or hours.

Your baby's breathing, blood pressure, oxygen levels, and other vital signs will be watched closely during treatment with beractant. This will help your doctor determine how long to continue treatment with beractant. Your child may also need blood tests.

Side Effects Centers
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.